These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 7983765)
41. Use of the meridian test for the detection of equine herpesvirus type 1 infection in horses with decreased performance. Chvala S; Nowotny N; Kotzab E; Cain M; van den Hoven R J Am Vet Med Assoc; 2004 Aug; 225(4):554-9. PubMed ID: 15344363 [TBL] [Abstract][Full Text] [Related]
42. Absence of viral antigens on the surface of equine herpesvirus-1-infected peripheral blood mononuclear cells: a strategy to avoid complement-mediated lysis. van der Meulen KM; Nauwynck HJ; Pensaert MB J Gen Virol; 2003 Jan; 84(Pt 1):93-97. PubMed ID: 12533704 [TBL] [Abstract][Full Text] [Related]
43. Innate immune responses of airway epithelial cells to infection with equine herpesvirus-1. Soboll Hussey G; Ashton LV; Quintana AM; Lunn DP; Goehring LS; Annis K; Landolt G Vet Microbiol; 2014 May; 170(1-2):28-38. PubMed ID: 24560592 [TBL] [Abstract][Full Text] [Related]
44. Equine Herpesvirus Type 1 Enhances Viral Replication in CD172a+ Monocytic Cells upon Adhesion to Endothelial Cells. Laval K; Favoreel HW; Poelaert KC; Van Cleemput J; Nauwynck HJ J Virol; 2015 Nov; 89(21):10912-23. PubMed ID: 26292328 [TBL] [Abstract][Full Text] [Related]
45. Equid herpesvirus (EHV-1) live vaccine strain C147: efficacy against respiratory diseases following EHV types 1 and 4 challenges. Patel JR; Földi J; Bateman H; Williams J; Didlick S; Stark R Vet Microbiol; 2003 Mar; 92(1-2):1-17. PubMed ID: 12488066 [TBL] [Abstract][Full Text] [Related]
46. Interactions between equine herpesvirus type 1 and equine herpesvirus type 4: T cell responses in a murine infection model. Azmi M; Field HJ J Gen Virol; 1993 Nov; 74 ( Pt 11)():2339-45. PubMed ID: 8245851 [TBL] [Abstract][Full Text] [Related]
47. Exogenous Expression of Equine MHC Class I Molecules in Mice Increases Susceptibility to Equine Herpesvirus 1 Pulmonary Infection. Minato E; Aoshima K; Kobayashi A; Ohnishi N; Sasaki N; Kimura T Vet Pathol; 2019 Sep; 56(5):703-710. PubMed ID: 30866742 [TBL] [Abstract][Full Text] [Related]
48. Equine major histocompatibility complex class I molecules act as entry receptors that bind to equine herpesvirus-1 glycoprotein D. Sasaki M; Hasebe R; Makino Y; Suzuki T; Fukushi H; Okamoto M; Matsuda K; Taniyama H; Sawa H; Kimura T Genes Cells; 2011 Apr; 16(4):343-57. PubMed ID: 21306483 [TBL] [Abstract][Full Text] [Related]
49. In vitro cytotoxic activity of equine lymphocytes on equine herpesvirus-1 infected allogenic fibroblasts. Edens LM; Crisman MV; Toth TE; Ahmed SA; Murray MJ Vet Immunol Immunopathol; 1996 Jul; 52(3):175-89. PubMed ID: 8809999 [TBL] [Abstract][Full Text] [Related]
50. Equine herpesvirus type 4 UL56 and UL49.5 proteins downregulate cell surface major histocompatibility complex class I expression independently of each other. Said A; Azab W; Damiani A; Osterrieder N J Virol; 2012 Aug; 86(15):8059-71. PubMed ID: 22623773 [TBL] [Abstract][Full Text] [Related]
51. Infection of peripheral blood mononuclear cells with neuropathogenic equine herpesvirus type-1 strain Ab4 reveals intact interferon-α induction and induces suppression of anti-inflammatory interleukin-10 responses in comparison to other viral strains. Wagner B; Wimer C; Freer H; Osterrieder N; Erb HN Vet Immunol Immunopathol; 2011 Sep; 143(1-2):116-24. PubMed ID: 21764140 [TBL] [Abstract][Full Text] [Related]
52. Genetic restriction of cytolysis during equid herpesvirus 1 subtype 2 infection. Bridges CG; Edington N Clin Exp Immunol; 1987 Nov; 70(2):276-82. PubMed ID: 2827921 [TBL] [Abstract][Full Text] [Related]
56. Characterization of the cytolytic T-lymphocyte response to a candidate vaccine strain of equine herpesvirus 1 in CBA mice. Smith PM; Zhang Y; Jennings SR; O'Callaghan DJ J Virol; 1998 Jul; 72(7):5366-72. PubMed ID: 9620990 [TBL] [Abstract][Full Text] [Related]
57. Immune escape of equine herpesvirus 1 and other herpesviruses of veterinary importance. van der Meulen KM; Favoreel HW; Pensaert MB; Nauwynck HJ Vet Immunol Immunopathol; 2006 May; 111(1-2):31-40. PubMed ID: 16472872 [TBL] [Abstract][Full Text] [Related]
58. Use of DNA and recombinant canarypox viral (ALVAC) vectors for equine herpes virus vaccination. Minke JM; Fischer L; Baudu P; Guigal PM; Sindle T; Mumford JA; Audonnet JC Vet Immunol Immunopathol; 2006 May; 111(1-2):47-57. PubMed ID: 16580075 [TBL] [Abstract][Full Text] [Related]
59. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus. Holmes MA; Townsend HG; Kohler AK; Hussey S; Breathnach C; Barnett C; Holland R; Lunn DP Vet Immunol Immunopathol; 2006 May; 111(1-2):67-80. PubMed ID: 16476488 [TBL] [Abstract][Full Text] [Related]
60. Glycoproteins D of equine herpesvirus type 1 (EHV-1) and EHV-4 determine cellular tropism independently of integrins. Azab W; Osterrieder N J Virol; 2012 Feb; 86(4):2031-44. PubMed ID: 22171258 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]